Data Sovereignty vs. Dollars: Ghana Declines $109M U.S. Health Deal
ACCRA, Ghana — In a move that underscores the growing tension between international aid and digital privacy, the government of Ghana has formally...
A New Chapter for Diabetes Care: Health Canada Approves First Generic ‘Ozempic’
April 29, 2026 In a landmark decision for North American healthcare, Health Canada has authorized the first generic version of semaglutide, the...
A New Map for the Spectrum: Federal Panel Urges Recognition of ‘Profound Autism’
April 29, 2026 WASHINGTON — In a move that could fundamentally reshape how the United States funds, researches, and treats neurodivergence, a...
New Dual-Action Therapy Survodutide Achieves 16.6% Weight Loss in Landmark Phase III Trial
Published: April 29, 2026 INGELHEIM, Germany — In a major development for the global effort to combat the obesity epidemic, pharmaceutical partners...
FDA Proposes Withdrawal of Amgen’s Tavneos: Safety Concerns and Efficacy Doubts Cloud Future of Vasculitis Treatment
April 29, 2026 The U.S. Food and Drug Administration (FDA) has taken the rare and significant step of proposing the withdrawal of Tavneos...
